Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.37% | -1.41% | 6.61% | 63.10% | 115.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.37% | -1.41% | 6.61% | 63.10% | 115.93% |
| Cost of Revenue | -6.64% | 4.09% | 1.51% | 54.94% | 240.04% |
| Gross Profit | 35.96% | -3.87% | 9.30% | 67.54% | 71.82% |
| SG&A Expenses | 26.76% | -1.12% | 3.54% | 53.96% | 99.39% |
| Depreciation & Amortization | 1.62% | -2.95% | 6.36% | 118.56% | 553.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.71% | -3.62% | -0.97% | 53.92% | 154.83% |
| Operating Income | 105.47% | 11.60% | 58.54% | 125.83% | -9.12% |
| Income Before Tax | 295.48% | 1,311.36% | -1.31% | 2,149.78% | -36.28% |
| Income Tax Expenses | -192.74% | 2,057.39% | -118.45% | 238.06% | -6.73% |
| Earnings from Continuing Operations | 538.68% | 1,160.31% | 76.30% | 5,093.99% | -44.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 538.68% | 1,160.31% | 76.30% | 5,093.99% | -44.97% |
| EBIT | 105.47% | 11.60% | 58.54% | 125.83% | -9.12% |
| EBITDA | 57.78% | 14.61% | 28.76% | 105.58% | 45.17% |
| EPS Basic | 538.70% | 1,149.05% | 77.89% | 4,243.18% | -59.15% |
| Normalized Basic EPS | 114.83% | 44.64% | -4.63% | 95.84% | -41.84% |
| EPS Diluted | 547.83% | 1,126.62% | 82.87% | 4,218.18% | -59.65% |
| Normalized Diluted EPS | 115.60% | 41.52% | -5.90% | 95.27% | -41.80% |
| Average Basic Shares Outstanding | 0.01% | 1.03% | -0.84% | 19.45% | 34.69% |
| Average Diluted Shares Outstanding | -0.35% | 3.26% | 0.50% | 19.80% | 34.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |